비뇨기용 기기 시장 예측(-2028년) - 제품 유형, 기술, 용도, 판매 채널, 최종사용자 및 지역별 세계 분석

According to Stratistics MRC, the Global Urology Devices Market is accounted for $40.31 billion in 2022 and is expected to reach $57.51 billion by 2028 growing at a CAGR of 6.1% during the forecast period. Medical equipment called urology devices is used to identify different urologic illnesses. Several urologic problems, such as urinary tract infections (UTI), kidney illness, urethral cancer, urine incontinence, urolithiasis, and others, can be treated with the use of these cutting-edge procedures.

According to the European Association of Urology, up to 31% of sepsis cases begin as UTIs, accounting for 2.8 million to 9.8 million cases in the US and Europe and resulting in as many as 1.6 million fatalities.

Market Dynamics:

Driver:

Increasing prevalence of urological diseases

Chronic renal failure that progresses to ESRD is brought on by uncontrolled diabetes and untreated high blood pressure. Additionally, kidney stone illness is becoming more commonplace around the globe. Western nations frequently experience kidney stone illness. In Western nations, the lifetime prevalence of kidney stone disease varies from 8% to 12% for males and 5% to 7% for women. The most frequent risk factor for kidney stone disease is obesity. In OECD nations, approximately one in six kids and more than one in two adults are overweight or obese. Therefore, it is anticipated that throughout the projected period.

Restraint:

Adverse Effects of Cystoscopes

Due to a number of adverse consequences, including infections, haemorrhage, urine retention, and bladder perforation, the market adoption of cystoscopes has plummeted. According to MMR, the number of UTI infections related to office cystoscopy increased by 10-20% in 2020. It is anticipated that these adverse effects would limit the usage of cystoscopes to some extent. Additionally, the market expansion is being hampered by the high cost of urology equipment. Numerous governments and organisations are teaching urology hospitals about the drawbacks associated with the use of these devices. These infections connected to urology devices are predicted to impede market expansion.

Opportunity:

Emergence of innovative technologies

One of the main difficulties of BPH therapy is dealing with sexual issues. Ejaculation issues and ED have been connected to the routinely used TURP therapy for BPH. Therefore, those who are worried about maintaining their sexual function should choose UroLift. For lithotripsy in the treatment of kidney stones, thulium fibre lasers (TFLs) are being researched as a potential substitute for the holmium laser. In terms of lithotripsy, the TFL has a number of potential benefits over holmium lasers, including a four-fold lower ablation threshold, a nearly single-mode beam profile, and greater pulse rates.

Threat:

Limitations and risk factors associated with urology devices

Pneumoembolism from dialysis catheters linked to vein thrombosis is possible. An intraluminal occlusion results from the fibrin sheath becoming occluded during thrombosis. Furthermore, those who undergo catheterization are at a greater risk of CLABSI (Central Line-Associated Bloodstream Infections). Dialysis catheter misplacement can lead to clotting, infection, and kinking. Therefore, the market's growth potential would be hampered over the projection period by the dangers and issues related to urological catheters.

COVID-19 Impact:

The COVID-19 outbreak has caused disruptions in global health systems. This has had a big influence on urological therapy and urology medical professionals. Numerous healthcare facilities are now overrun by very ill patients as a result of the rising COVID-19 instances throughout the world. The COVID-19 strain commonly causes patients to experience severe respiratory distress, which may occasionally result in acute renal impairment and kidney failure. The increased number of COVID-19-infected people throughout the world is anticipated to result in an increase in the requirement for dialysis procedures.

The instruments segment is expected to be the largest during the forecast period

The instruments segment is estimated to have a lucrative growth. This market is expanding as a consequence of improving research and the growing usage of minimally invasive procedures. Some of the most frequently used urology devices include catheters, cystoscopy, endoscopes, bladder forceps, kidney and kidney stone forceps, optical stone forceps, urethra forceps, visual cystoscopic instruments, flexible cystoscopic instruments, hohenfellner, prostatectomy instruments, and precise spermatic instruments.

The hospitals and clinics segment is expected to have the highest CAGR during the forecast period

The hospitals and clinics segment is anticipated to witness the fastest CAGR growth during the forecast period, due to the increasing number of hospitals and clinics around the world. One of the main reasons propelling the growth of this market is the increased demand for minimally invasive operations, technical advancements in surgical techniques, and growing public awareness of urological problems and their early identification and treatment. Government programmes including funding for the construction of healthcare facilities are also anticipated to fuel market expansion throughout the projected timeframe.

Region with highest share:

Europe is projected to hold the largest market share during the forecast period. Stress urine incontinence and symptoms of an overactive bladder are common among patients. One in three women in this area suffers from urinary incontinence, which is thought to be more frequent than hay fever. The prevalence of urology patients in hospitals has led to an increase in technical developments for treating these disorders. The regional market is anticipated to expand considerably due to the rising incidences and prevalence of urinary problems in the area as well as the high per capita healthcare spending.

Region with highest CAGR:

North America is projected to have the highest CAGR over the forecast period. Benign prostatic hyperplasia (BPH) is one of the most underserved sectors in the urology sector, and several US-based companies are working to enhance their offerings in this space through collaborations or acquisitions. While girls are more prone to develop infections as they age, boys are more likely to do so before they are a year old. Additionally, the most common outpatient infections in adult women are urinary tract infections (UTIs), which have a lifetime prevalence of between 50 and 60 percent. UTIs account for a large percentage of yearly medical visits in the United States. As a result of increased urological equipment sales, this condition propels the market. The societal and personal costs of UTIs are enormous.

Key players in the market:

Some of the key players profiled in the Urology Devices Market include Medtronic Plc, Boston Scientific Corp., Olympus Corp., Urotech Devices, Richard Wolf GmbH, Stryker Corp., Siemens AG, Baxter International Inc., Cook Medical Incorporated, Karl Storz SE & Co. KG, Becton, Dickinson and Company, Endo Pharmaceuticals Inc, Cardinal Health and Intuitive Surgical.

Key Developments:

In June 2020, Olympus Corporation introduced the Soltive SuperPulsed Laser System in the US as a device for urologists to use for soft tissue treatment and stone lithotripsy.

Product Types Covered:

• Consumables & Accessories
• Retrieval Devices & Extractors
• Endoscopy Fluid Management Systems
• Dilator Sets & Urethral Access Sheaths
• Insufflators
• Surgical Dissectors, Forceps, & Needle Holders
• Instruments
• Other Product Types

Technologies Covered:

• Robotic Surgery
• Minimally Invasive
• Other Technologies

Applications Covered:

• Pelvic Organ Prolapse
• Kidney Diseases
• Cancer and BPH
• Bladder Cancer
• Prostate Cancer
• Other Applications

Sales Channels Covered:

• Medical Stores & Brand Outlet
• Online Retailing

End Users Covered:

• Home Healthcare
• Hospitals & Clinics
• Dialysis Centers
• Ambulatory Surgical Centers
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 Technology Analysis
• 3.8 Application Analysis
• 3.9 End User Analysis
• 3.10 Emerging Markets
• 3.11 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Urology Devices Market, By Product Type

• 5.1 Introduction
• 5.2 Consumables & Accessories
  • 5.2.1 Guidewires
  • 5.2.2 Dialysis Consumables
  • 5.2.3 Drainage Bags
  • 5.2.4 Stents
  • 5.2.5 Catheters
  • 5.2.6 Tubes & Distal Attachments
  • 5.2.5 Biopsy Devices
• 5.3 Retrieval Devices & Extractors
• 5.4 Endoscopy Fluid Management Systems
• 5.5 Dilator Sets & Urethral Access Sheaths
• 5.6 Insufflators
• 5.5 Surgical Dissectors, Forceps, & Needle Holders
• 5.8 Instruments
  • 5.8.1 Peripheral Instruments
  • 5.8.2 Endoscopes
    • 5.8.2.1 Cystoscopes
    • 5.8.2.2 Laparoscopes
    • 5.8.2.3 Resectoscopes
    • 5.8.2.4 Ureteroscopes
    • 5.8.2.5 Nephroscopes
    • 5.8.2.6 Other Endoscopes
  • 5.8.3 Dialysis Devices
    • 5.8.3.1 Peritoneal Dialysis Devices
    • 5.8.3.2 Hemodialysis Devices
  • 5.8.4 Laser & Lithotripsy Devices
  • 5.8.5 Robotic Systems
  • 5.8.6 Endovision & Imaging Devices
  • 5.8.5 Urodynamic Systems
• 5.9 Other Product Types

6 Global Urology Devices Market, By Technology

• 6.1 Introduction
• 6.2 Robotic Surgery
• 6.3 Minimally Invasive
• 6.4 Other Technologies

7 Global Urology Devices Market, By Application

• 7.1 Introduction
• 7.2 Pelvic Organ Prolapse
• 7.3 Kidney Diseases
• 7.4 Cancer and BPH
• 7.5 Bladder Cancer
• 7.6 Prostate Cancer
• 7.7 Other Applications

8 Global Urology Devices Market, By Sales Channel

• 8.1 Introduction
• 8.2 Medical Stores & Brand Outlet
• 8.3 Online Retailing

9 Global Urology Devices Market, By End User

• 9.1 Introduction
• 9.2 Home Healthcare
• 9.3 Hospitals & Clinics
• 9.4 Dialysis Centers
• 9.5 Ambulatory Surgical Centers
• 9.6 Other End Users

10 Global Urology Devices Market, By Geography

• 10.1 Introduction
• 10.2 North America
  • 10.2.1 US
  • 10.2.2 Canada
  • 10.2.3 Mexico
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 Italy
  • 10.3.4 France
  • 10.3.5 Spain
  • 10.3.6 Rest of Europe
• 10.4 Asia Pacific
  • 10.4.1 Japan
  • 10.4.2 China
  • 10.4.3 India
  • 10.4.4 Australia
  • 10.4.5 New Zealand
  • 10.4.6 South Korea
  • 10.4.7 Rest of Asia Pacific
• 10.5 South America
  • 10.5.1 Argentina
  • 10.5.2 Brazil
  • 10.5.3 Chile
  • 10.5.4 Rest of South America
• 10.6 Middle East & Africa
  • 10.6.1 Saudi Arabia
  • 10.6.2 UAE
  • 10.6.3 Qatar
  • 10.6.4 South Africa
  • 10.6.5 Rest of Middle East & Africa

11 Key Developments

• 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 11.2 Acquisitions & Mergers
• 11.3 New Product Launch
• 11.4 Expansions
• 11.5 Other Key Strategies

12 Company Profiling

• 12.1 Medtronic Plc
• 12.2 Boston Scientific Corp.
• 12.3 Olympus Corp.
• 12.4 Urotech Devices
• 12.5 Richard Wolf GmbH
• 12.6 Stryker Corp.
• 12.7 Siemens AG
• 12.8 Baxter International Inc.
• 12.9 Cook Medical Incorporated
• 12.10 Karl Storz SE & Co. KG
• 12.11 Becton, Dickinson and Company
• 12.12 Endo Pharmaceuticals Inc
• 12.13 Cardinal Health
• 12.14 Intuitive Surgical